Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 129764, 6 pages
http://dx.doi.org/10.1155/2015/129764
Research Article

Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical Study

1Nuclear Medicine, University “Aldo Moro”, Piazza Giulio Cesare 11, 70124 Bari, Italy
2Nuclear Medicine, Hospital “Spirito Santo”, Pescara, Italy
3Advanced Center Oncology Macerata (ACOM) S.p.A., Montecosaro, Italy

Received 3 September 2015; Accepted 22 October 2015

Academic Editor: Bianca Gutfilen

Copyright © 2015 Cristina Ferrari et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. A. Reardon, J. N. Rich, H. S. Friedman, and D. D. Bigner, “Recent advances in the treatment of malignant astrocytoma,” Journal of Clinical Oncology, vol. 24, no. 8, pp. 1253–1265, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Niccoli Asabella, G. L. Cascini, C. Altini, D. Paparella, A. Notaristefano, and G. Rubini, “The copper radioisotopes: a systematic review with special interest to 64Cu,” BioMed Research International, vol. 2014, Article ID 786463, 9 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. J. T. Jørgensen, M. Persson, J. Madsen, and A. Kjær, “High tumor uptake of 64Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers,” Nuclear Medicine and Biology, vol. 40, no. 3, pp. 345–350, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Qin, H. Liu, K. Chen et al., “Theranostics of malignant melanoma with 64CuCl2,” Journal of Nuclear Medicine, vol. 55, no. 5, pp. 812–817, 2014. View at Publisher · View at Google Scholar
  5. E. Capasso, S. Durzu, S. Piras et al., “Role of 64CuCl2 PET/CT in staging of prostate cancer,” Annals of Nuclear Medicine, vol. 29, no. 6, pp. 482–488, 2015. View at Publisher · View at Google Scholar
  6. F. Peng, X. Lu, J. Janisse, O. Muzik, and A. F. Shields, “PEt of human prostate cancer xenografts in mice with increased uptake of 64CuCl2,” Journal of Nuclear Medicine, vol. 47, no. 10, pp. 1649–1652, 2006. View at Google Scholar · View at Scopus
  7. L. Evangelista, M. Luigi, and G. L. Cascini, “New issues for copper-64: from precursor to innovative PET tracers in clinical oncology,” Current Radiopharmaceuticals, vol. 6, no. 3, pp. 117–123, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. M. A. Cater, H. B. Pearson, K. Wolyniec et al., “Increasing intracellular bioavailable copper selectively targets prostate cancer cells,” ACS Chemical Biology, vol. 8, no. 7, pp. 1621–1631, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. C. L. Ferreira, D. T. T. Yapp, S. Crisp et al., “Comparison of bifunctional chelates for 64Cu antibody imaging,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 37, no. 11, pp. 2117–2126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. C. F. Ramogida and C. Orvig, “Tumour targeting with radiometals for diagnosis and therapy,” Chemical Communications, vol. 49, no. 42, pp. 4720–4739, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. K. S. Woodin, K. J. Heroux, C. A. Boswell et al., “Kinetic inertness and electrochemical behavior of copper(II) tetraazamacrocyclic complexes: possible implications for in vivo stability,” European Journal of Inorganic Chemistry, vol. 2005, no. 23, pp. 4829–4833, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. A. S. Tavares and J. M. R. S. Tavares, “Tc99m Auger electrons for targeted tumour therapy: a review,” International Journal of Radiation Biology, vol. 86, no. 4, pp. 261–270, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Beaino, Y. Guo, A. J. Chang, and C. J. Anderson, “Roles of Atox1 and p53 in the trafficking of copper-64 to tumor cell nuclei: implications for cancer therapy,” Journal of Biological Inorganic Chemistry, vol. 19, no. 3, pp. 427–438, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Ishida, P. Andreux, C. Poitry-Yamate, J. Auwerx, and D. Hanahan, “Bioavailable copper modulates oxidative phosphorylation and growth of tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 48, pp. 19507–19512, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. C. S. Cutler, H. M. Hennkens, N. Sisay, S. Huclier-Markai, and S. S. Jurisson, “Radiometals for combined imaging and therapy,” Chemical Reviews, vol. 113, no. 2, pp. 858–883, 2013. View at Publisher · View at Google Scholar · View at Scopus